Targeting inflamed and non-inflamed melanomas: biological background and clinical challenges
Alice Indini1, Daniela Massi2, Matteo Pirro3, Fausto Roila4, Francesco Grossi1,5, Amirhossein Sahebkar6, Nicole Glodde7, Tobias Bald7, Mario Mandalà4
1Division of Medical Oncology, Department of Medicine and Surgery, Ospedale di Circolo e Fondazione Macchi, ASST dei Sette Laghi, Varese, Italy
2Section of Pathological Anatomy, Department of Health Sciences, University of Florence, Florence, Italy
3University of Perugia, Department of Medicine and Surgery, Unit of Internal Medicine, Perugia, Italy
4University of Perugia, Department of Surgery and Medicine, Unit of Medical Oncology, Perugia, Italy
5Division of Medical Oncology, University of Insubria, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
6Biotechnology Research Center, Pharmaceutical Technology Institute & Neurogenic Inflammation Research Center & School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
7Laboratory of Tumor-Immunobiology, Institute of Experimental Oncology (IEO), University Hospital Bonn, University of Bonn, Bonn, Germany
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Seminars in Cancer Biology
Tập 86
477-490
Thông tin tác giả